The present invention provides novel compounds of formula (I) that are potent and selective non-covalent caspase inhibitors. These compounds nay be used for the treatment of inflammatory diseases.
Shtark, A. V.; Kizner, T. A.; Shteingarts, V. D., Journal of Organic Chemistry USSR (English Translation), 1982, vol. 18, p. 2051 - 2056
作者:Shtark, A. V.、Kizner, T. A.、Shteingarts, V. D.
DOI:——
日期:——
COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS
申请人:Ionis Pharmaceuticals, Inc.
公开号:US20170145424A1
公开(公告)日:2017-05-25
Provided herein are compositions and methods for non-parenteral delivery of conjugated oligomeric compounds. In certain embodiments, compositions and methods are provided for oral delivery of conjugated oligomeric compounds. In certain embodiments, the oligomeric compounds are conjugated to one or more N-acetylgalactosamines or N-acetylgalactosamine analogues.
Some Reactions of Tetrafluorobenzyne with Halogens and Ethers, and with Alcohols